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Background: Hospital Acquired Acute Kidney Injury (HA-AKI) prevalence has not been analysed in a South African setting. 
We investigated HA-AKI prevalence, using the KDIGO definition, with clinical characteristics and outcomes. The aim was to 
provide evidence for earlier treatment interventions to improve outcomes, such as recent UK NHS initiatives of  automated 
electronic alerts in the laboratory information system. 
Methods: Retrospective laboratory and clinical data was analysed for a 6-month period at Tygerberg Hospital, Cape Town. Se-
rum creatinine results and clinical records were analysed and collated into gender and age group specific results. 
Results: HA-AKI occurred in 6.2% of  hospitalised patients for the period of  analysis. The highest incident occurred in females 
aged 18-39 and males aged 40-59. The most common AKI stage reached was stage 1. HA-AKI increased length of  stay by an 
average of  4.6 days and 20% of  patients were readmitted at a later date with renal dysfunction. 
Conclusion: AKI prevalence is significant and associated with adverse patient outcomes. Initiatives that allow front-line health-
care professionals to treat and manage AKI, such as introduction of  automated electronic alerts, should be considered. Similar 
initiatives have been implemented in UK NHS hospitals with positive impacts. 
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Introduction
A common complication affecting hospital in-patients 
worldwide is acute kidney injury (AKI)1-3. Characterised 
by rapid decline in kidney function and oliguria, it is as-
sociated with adverse long-term outcomes and high mor-
tality.  The Kidney Disease Improving Global Outcomes 
(KDIGO) clinical guideline states that AKI is defined and 
staged based on an increase in Serum Creatinine (SCr) 
concentration and reduction in urine output. The effects 
are both short and long-term and even a minor acute 
reduction in kidney function has an adverse prognosis. 
Several studies have confirmed that severity and duration 
of  AKI determines outcome2,4,5. Although common and 
harmful, AKI is potentially preventable and treatable.
There has been a global drive for earlier recognition and 
prevention strategies as this improves patient outcomes3. 
One strategy implemented by National Health Service 
(NHS) England was the introduction of  a national algo-
rithm to standardise the definition of  AKI4,5. This algo-
rithm was agreed in the United Kingdom (UK) in June 
2014 and was integrated into the Laboratory Information 
Management Systems (LIMS) used by UK NHS hospi-
tals. It identifies and stages real-time potential cases of  
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Hospital Acquired Acute Kidney Injury (HA-AKI) using 
the current laboratory results and previous laboratory 
results linked to the patient’s records, sending results to 
patient management systems for urgent intervention, to 
ensure timely and consistent approaches. Data from ear-
lier UK based studies on AKI prevalence rates, patient 
outcomes and predicted cost implications were a major 
driving force for such initiatives1,2. Therefore the data 
from this study may provide evidence for the introduc-
tion of  similar strategies. 
Overall global AKI incident rates are not well known 
and recent studies conducted in multiple countries have 
shown wide disparity in reported incident rates6. Previous 
2014 UK based studies estimated that 14-20% of  hospi-
talised patients developed AKI, 2.1% of  which is hos-
pital-acquired, with a suggested 20-30% preventable1,6,7. 
It was also suggested that patients most at risk of  de-
veloping AKI whilst in a UK hospital were aged >70, 
with mean age of  74.41,6. The overall conclusions were 
that AKI is associated with a high number of  in-hospi-
tal deaths with high healthcare costs1,8. The purpose of  
this study was to determine the prevalence of  HA-AKI 
at Tygerberg Hospital, Cape Town, a less economically 
developed healthcare setting, to compare the prevalence 
with the UK study, and estimate the impact on both the 
patient and healthcare system.
Methods and materials
Study site
A retrospective audit of  laboratory and clinical records 
of  finished hospital admissions at Tygerberg Hospital 
for a given 6 month period (01/12/2015-01/06/2016) 
was performed. Tygerberg Hospital is a tertiary hospital 
in Cape Town, South Africa and provides inpatient and 
outpatient care to public health-sector users9. It is a 1,400 
bed multidisciplinary teaching hospital affiliated with 
Stellenbosch University. The National Health Laboratory 
Service (NHLS) Chemical Pathology laboratory at Tyger-
berg Hospital provides 24 hour diagnostic service. The 
NHLS is the preferred provider of  pathology services to 
the public health-sector.
Definitions
HA-AKI incidence was estimated using the number of  
patients that developed biochemical markers indicative 
of  AKI in line with the KDIGO definition whilst in hos-
pital, out of  the total number of  inpatient admissions for 
the stated six month period. Patients admitted through 
Accident and Emergency (A&E) and hospital outpa-
tient clinics were included. The analysis was restricted to 
patients aged >18 and excluded day case and maternity 
admissions and any patients with AKI on initial hospital 
presentation.
Laboratory data collection
Laboratory data for the specified dates and specific re-
questing locations (Tygerberg Hospital wards and outpa-
tients only) was extracted from the LIMS used at Tyger-
berg Hospital (Disa*Lab), and collated anonymously into 
a Microsoft Excel spread sheet before subsequent anal-
ysis. This data included; patient age at referral, gender, 
unique medical record number, unique hospital folder 
number, serial serum creatinine (SCr) results (µmol/L), 
serial serum urea results (mmol/L), serial electrolyte re-
sults (Na, K, Cl). 
The cohort was divided by gender to create two sepa-
rate spread sheets; male and female. The results were 
then grouped according to the patient unique identifier 
in date order to allow serial results for each patient to be 
analysed. In order to include only patients that developed 
biomarkers indicative of  AKI during their stay as an inpa-
tient at Tygerberg Hospital, only patients that had a nor-
mal baseline SCr on admission, that increased in line with 
the KDIGO definition >48 hours post admission whilst 
under hospital care were included8. All patients with nor-
mal serial SCr results during their hospital stay or raised 
SCr on initial presentation were therefore excluded and 
the results removed. Patients with >3 serial SCr results 
that increased in line with the KDIGO definition of  AKI 
during their hospital stay were included6,8. The two data 
sets (males and females) were then further sub-grouped 
into four age groups; 18-39, 40-59, 60-79, 80+. This cre-
ated a total data set of  8 sub-groups on separate spread 
sheets for analysis. 
Clinical data collection
Hospital admission data, cause of  the AKI, length of  
hospital stay and readmission data was analysed using the 
electronic medical record system available at Tygerberg 
Hospital. Due to time restraints, a sample population co-
hort was used. Medical records for a cohort of  10 males 
and 10 females from each of  the 4 age groups, creating 
a total of  80 patients, was analysed in detail. All data was 
extracted anonymously into an Excel spread sheet for 
subsequent analysis. The total number of  hospital in-pa-
tient admissions for the specified dates was accessed from 
the hospital admissions record office. 
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Laboratory analysis
Laboratory analysis of  SCr was performed on a Siemens 
Advia® 1800 automated analyser at Tygerberg Hospital 
Chemical Pathology laboratory using the Jaffe method. 
The reference ranges used for SCr analysis were taken 
from the standard operating procedure (SOP) at Tyger-
berg Hospital NHLS Chemical Pathology Laboratory 
CHE0410. This SOP states gender specific reference 
ranges for SCr measurement in patients aged >18 are as 
follows; Males 64–104 µmol/L, Females 49–90 µmol/L. 
Serial SCr results for each patient were analysed to de-
termine AKI staging and where possible clinical records 
were analysed for recorded urine output. These results 
were also analysed to determine renal recovery post-AKI 
before discharge. Serum U&E were analysed for further 
evidence of  decline in renal function. Clinical records for 
a sample population of  each sub-group were analysed 
to determine initial diagnosis, hospital stay duration and 
where possible patient outcome in terms of  increased 
length of  stay and return hospital visit with abnormal re-
nal function.
Numerical analysis
To analyse AKI prevalence for each sub-group, in rela-
tion to total in-patients, data from Tygerberg Hospital ad-
mission report was accessed. As an estimate of  associated 
HA-AKI risk factors clinical records were analysed to de-
termine initial presentation and diagnosis for a sub-set of  
80 patients; 10 males and 10 females in each of  the 4 age 
groups. Patients were selected based on age (to ensure the 
whole age range was represented) and completeness of  
biochemistry results available. To provide an insight into 
the impact on patient outcomes and hospital resources, 
clinical records for the same 80 patients were analysed 
to determine total length of  hospital stay, length of  stay 
after AKI diagnosis and recurrent admission since the 
initial HA-AKI with abnormal renal function.
Results
The total number of  inpatient hospital admissions for 
the given 6 month time period was 18,781. Using retro-
spective analysis of  laboratory and clinical records, total 
number of  patients aged >18 with a diagnosis of  AKI 
was 2,760 and therefore total prevalence of  AKI at Ty-
gerberg Hospital (community and hospital acquired) was 
estimated to be 14.7%. The total number of  patients aged 
>18 that developed HA-AKI was 1,165. It was therefore 
concluded that total HA-AKI prevalence for Tygerberg 
Hospital for the given 6 month period was 6.2%. The 
characteristics of  the 1,165 patients used in this study are 
shown in table 1.
Patients were sub-grouped according to gender and age 
group. Of  the 1,165 cases of  HA-AKI, 689 were female 
(59.1%) and 476 (40.9%) were males. Analysis of  age 
group incidence showed highest prevalence occurred in 
females aged 18-39 (294 cases) and males aged 40-59 (195 
cases).  Results for the total number of  patients that de-
veloped HA-AKI for each of  the 8 sub-groups are shown 
in figure 1.
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Figure 1 – the total number of patients for each age group of males and females 
that developed biochemical markers indicative of acute kidney injury, 
in line with the KDIGO definition of AKI, during their stay as 
an in-patient at tygerberg tertiary hospital.
Table 1. Characteristics of patients with hospital acquired acute kidney injury (N=1165) 
 
Variable Study Cohort 
Age(years)(mean + SE) 46 + 0.4 
Gender (male:female) 1:1.45 
Total hospital stay (days) (mean + SE) 10.8 + 2.1 
Study entry serum creatinine (µmol/L) (mean + SE) 55.9 + 0.15 
Study entry serum urea (mmol/L) (mean + SE) 4.4 + 0.01 
Peak serum creatinine (µmol/L) (mean + SE) 380.1 + 4.48 
Peak serum urea (mmol/L) (mean + SE) 20.43 + 0.17 
Reason forhospital admission in select sub-group: 




Immunocompromised (SLE, AIDS, 
Immunotherapy, Malignancy) 
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AKI staging was determined using the KDIGO AKI 
definition of  changes in serum creatinine over time, using 
the lowest serum creatinine measurement from the same 
admission as baseline, and highest SCr reached during 
the same admission for severity staging. The results of  
which, as expected, showed the most common AKI stage 
reached was an AKI stage 1, with some patients progress-
ing to a stage 2 or 3. The results for AKI staging in fe-
males are shown in figure 2, and AKI staging in males in 
figure 3.
Figure 2 – The number of  female patients for each age group that developed 
biochemical markers indicative of  acute kidney injury stage 1, 2 and 3, in line with 
the KDIGO definition of  AKI, during their stay as an in-patient at Tygerberg 
Tertiary Hospital. The numbers above each bar are the exact number of  patients; 
the percentage value is the percentage of  patients that developed stage 1, 2 
and 3 for the given age group to the nearest whole number.
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Initial diagnosis at hospital admission was analysed for a 
sub-set of  10 patients (5 females and 5 males) that devel-
oped HA-AKI from each of  the 4 age groups, creating 
a subset of  80 patients. This showed the most common 
initial presentation and therefore risk factor for HA-AKI 
was infection, the second hypertension and third a surgi-
cal procedure. The initial diagnosis at hospital admission 
for the patient cohort used is summarised in table 1. Total 
length of  hospital stay and length of  stay post HA-AKI 
diagnosis was also analysed. This showed the mean in-
creased length of  stay after HA-AKI onset for the patient 
subset analysed was 4.6 days (mean = 4.6, SE = 0.79). 
The impact of  HA-AKI on increased length of  stay has 
both negative social and economic impacts.
Clinical records for separate patient admissions following 
the initial admission were also analysed, as well as labora-
tory results and clinical records for evidence of  abnormal 
renal function following the HA-AKI incident. This anal-
ysis provided an insight into long-term patient outcomes. 
The results showed that of  the subset of  80 patients an-
alysed, 25% were readmitted to hospital at a later date 
(20 out of  80 patients), with impaired renal function. The 
highest rate of  readmission was observed in females aged 
40-59 and males 60-79.
Discussion
The aim of  this study was to determine the prevalence of  
HA-AKI at Tygerberg Hospital, compare this to the pre-
viously published prevalencein the UK and estimate the 
impact of  HA-AKI on the patient and healthcare system.
AKI is a common and serious health complication af-
fecting a significant number of  hospital in-patients1,6,7. 
However, it is easily preventable and potentially treatable 
if  at risk patients are diagnosed early and monitored1. Re-
cently there has been a global drive in earlier recognition 
and prevention strategies to improve patient outcomes6. 
A key initiative implemented in UK NHS hospital labo-
ratories is the introduction of  automated electronic alerts 
in the LIMS5,8,10. Our study has provided an insight into 
rates of  HA-AKI in a SA hospital, and has contributed 
Figure 3 – The number of  male patients for each age group that developed biochemical markers indicative 
of  acute kidney injury stage 1, 2 and 3, in line with the KDIGO definition of  AKI, during their stay as 
an in-patient at Tygerberg Tertiary Hospital. The numbers above each bar are the exact number of  patients; 
the percentage value is the percentage of  patients that developed stage 1, 2 and 3 for the given age group 
to the nearest whole number.
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to the global need for epidemiology studies. The results 
found that 6.2% of  patients admitted to Tygerberg Hos-
pital for the given 6 month period developed HA-AKI. 
Similar studies have been completed in other global lo-
cations, with rates of  HA-AKI ranging from 1-7%1,3,11-15. 
A 2014 UK based study with comparable methodology 
found HA-AKI prevalence to be 2.1%1. An earlier 1996 
study also using comparable methods based in Chicago, 
USA, found that AKI developed in 7.2% of  hospital-
ised patients, with medications, surgery and radiographic 
contrast media use being the most common causes11.The 
significant increase in HA-AKI prevalence found in the 
1996 USA based study compared to the 2014 UK study 
may be due to medical advances and increased awareness. 
The results of  our study, which showed HA-AKI prev-
alence to be similar to the 1996 USA based study (6.2% 
and 7.2% respectively), may reflect the current compara-
tively naïve status of  the SA healthcare system.
The data from this study identified the most at risk patient 
cohort for the development of  HA-AKI were females 
aged 18-39 and males aged 40-59, with average age of  on-
set of  44 in females and 51 in males. A similarly designed 
2014 study conducted in South Western Ghana looking at 
AKI incidence from retrospective laboratory data found 
highest prevalence in the age group 20-39, with females 
at increased risk at a younger age12. A 2016 multicentre 
study of  AKI prevalence in ICU patients in Kinshasa, the 
Democratic Republic of  Congo found the average AKI 
patient age of  51.913. Both of  these independent studies 
therefore support our results. However, when compared 
to UK based studies, where average age of  AKI onset 
is ~74.4, this is a significantly younger age. The World 
Health Organization (WHO) 2015 statistics state life 
expectancy at birth for SA is 66 for females and 59 for 
males14. Comparatively, the UK life expectancy at birth is 
83 for females and 79 for males15. Therefore the relation-
ship of  HA-AKI onset later in life, closer to respective 
life expectancy is reflected in both the UK study and the 
African based studies, and is well supported by literature 
that shows a risk factor for AKI is increased age1,12,13. 
The highest prevalence of  HA-AKI in females aged 18-
39 found in this study reflects child bearing age and the 
well documented association of  pregnancy and AKI6. Al-
though patient samples from maternity were not includ-
ed, previous history of  pregnancy and child birth was not 
included in the clinical records analysed and therefore the 
high prevalence of  HA-AKI in females aged 18-39 may 
reflect the increased risk of  prior child bearing. It is widely 
recognised that AKI epidemiology differs in developing 
vs. developed countries in many important ways3,4. A pre-
vious 2008 study found that infections, nephrotoxins, and 
obstetric and surgical complications are amongst the ma-
jor causes of  AKI in Africa, with the most common risk 
factors being severe immune suppression and opportu-
nistic infection4,14,15. It was also found that HIV-1-infect-
ed patients with AKI have an increased risk of  in-hospital 
mortality 4. Due to time limitations of  our study, clinical 
details on infections and HIV status were not analysed, 
however it is recognised that these are important risk fac-
tors. Another key documented difference is the age of  
onset. In developed countries AKI predominantly occurs 
in the elderly, and thus increasing age is a significant risk 
factor3,4. On the other hand, in developing countries AKI 
is considered a disease of  the young4. The results of  this 
study therefore further support the increased prevalence 
of  AKI in younger patients in terms of  actual years, but 
not younger in terms of  stage of  life expectancy.
The analysis of  subsequent hospital admissions in a sub-
set of  patients identified that 20% of  the patients had 
been readmitted with laboratory results suggestive of  
abnormal renal function; with the highest re-admission 
observed in females aged 40-59 and males aged 60-79. In 
the 80+ cohort for both males and females, only 1% of  
patients was readmitted; perhaps due to mortality as this 
is well above the current SA life expectancy of  66 and 
59 for females and males respectively14. A recent 2016 
publication of  a systematic review and meta-analysis of  
hospital readmissions following an AKI event found that 
hospital readmission rates were 21%17. The results of  this 
study closely reflect that, with a readmission rate of  20%. 
Ideally, in order to directly compare these statistics this 
study should be extended to a 12 month period to account 
for seasonal changes. However, the readmission rate of  
20% is significant, which emphasises the importance and 
burden of  AKI on medical resources; which may have 
been preventable, further highlighting the importance of  
rapid AKI diagnostics and early kidney-sparing initiatives.
The development of  AKI on average increased hospi-
tal stay in our cohort by 4.6 days, which has significant 
economic impacts on the total cost of  patient care. Pre-
vious studies have reported similar supportive findings. 
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A 2011 American study looking at HA-AKI prevalence 
and outcomes concluded that HA-AKI increases hospital 
stay by on average 4 days17. This is a similar and support-
ive finding. This data should therefore provide evidence 
and encouragement for early diagnostic and prevention 
initiations. Patients that developed HA-AKI from all 
in-patient locations at Tygerberg Hospital were included 
in this study. It is however well recognised that Intensive 
Care Unit (ICU) patients are most at risk of  AKI devel-
opment, particularly within a low resource setting6,13,17,18. 
A recent 2016 multicentre study conducted in 7 ICU set-
tings from Kinshasa, the Democratic Republic of  Congo 
found that the cumulative incidence of  AKI in ICU pa-
tients was 52.7%18. This therefore identifies a particularly 
vulnerable patient cohort that could benefit from earlier 
diagnostic and intervention initiatives.
AKI is a challenging global burden, with significant 
health and cost implications. This therefore emphasises 
the importance of  finding and introducing improved di-
agnostic and treatment interventions. A strategy recently 
implemented in all UK NHS hospitals by NHS England, 
is the introduction of  a national algorithm to standardise 
AKI definition and allow real time identification of  po-
tential cases of  AKI from laboratory data, sending re-
sults to patient management systems for urgent interven-
tion4,5. This allows AKI to be detected and staged based 
on changes in biochemical markers in line with national 
guidelines and alerts the healthcare professionals to act 
accordingly in a timely and consistent approach. It should 
be noted that this automated electronic alert is only an 
aid to prompt early recognition of  AKI and should not 
be relied upon to detect AKI without close inspection 
of  serial blood test results and clinical evaluation1,4,5. AKI 
is a clinical diagnosis based on clinician review of  serial 
blood test results in the clinical context of  the individual 
patient and therefore this standard should be maintained. 
However, in a healthcare system such as that in SA where 
there is a significantly low ratio of  doctors to patients in 
the public setting, but an acceptable ratio of  healthcare 
professionals to patients, an initiative such as this could 
allow early awareness of  a patient at risk of  or that has 
developed an AKI19,20.
Our study had several limitations. Due to the medical 
record system at Tygerberg Hospital, identifying the ini-
tial diagnosis and cause of  AKI was extremely difficult. 
Handwritten notes are scanned into an electronic system, 
and are often incomplete and difficult to read. Due to 
the absence of  a national identity system in SA it is often 
difficult to see a patients full clinical history or follow a 
patient for long term outcomes once discharged from a 
hospital. We therefore were unable to access treatment, 
outcome or mortality data.
Unfortunately this study was performed over a short time 
term (KF's Elective) and therefore a repeat study over 
a 12 month period to include potential seasonal trends 
would be ideal. Our study was conducted in one Tertia-
ry Hospital; ideally repeat at multiple hospitals for a true 
representation of  the SA healthcare system. Infection 
and HIV status were not included in this study, but have 
been previously identified as a major cause of  AKII7,13,16.
Conclusion
HA-AKI prevalence at Tygerberg Tertiary Hospital for 
the given 6 month period was 6.2%. The most at risk 
patients were found to be females aged 18-39 and males 
aged 40-59; with mean age of  onset of  46 years. The most 
common HA-AKI staging reached was AKI stage 1. The 
onset of  HA-AKI increased hospital length of  stay by 
4.6 days on average, and had a 20% readmission rate 
with abnormal renal function. The most common initial 
presentation was an infection, followed by hypertension 
and then surgery. Public SA hospitals have a significantly 
low doctor to patient ratio (0.8:1000) but an acceptable 
healthcare professional to patient ratio (2.9:1000) and 
therefore interventions that will bring AKI to the atten-
tion of  healthcare professionals sooner should be investi-
gated19,20. One such intervention recently implemented by 
all UK NHS hospitals is the incorporation of  a national 
algorithm into the LIMS generating automated electronic 
alerts for urgent response. Such initiatives may be con-
sidered for implementation into the SA LIMS. The LIMS 
used at Tygerberg Hospital is TrakCare. The Association 
of  Clinical Biochemistry (ACB) national meeting state-
ment to discuss E-Alerts for AKI held in July 2013 show 
a TrakCare representative was absent, but incorporation 
of  this algorithm is technically possible10. AKI is a signif-
icant social and economic health burden and therefore 
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any interventions to improve early diagnosis and treat-
ment should be considered.
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